Tridesilon
Drug - Tridesilon
The trade name of the product as shown on the labeling.
Dosage -
OINTMENT; TOPICAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Desonide
Multiple ingredients are in alphabetical order.
Strength -
0.05%
The potency of the active ingredient(s), Desonide. May repeat for multiple part products.
Applicant -
CLAY PARK
The firm name holding legal responsibility for Tridesilon. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
017426
The FDA assigned number to Tridesilon. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Tridesilon. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Approved Prior to Jan 1, 1982
The date Tridesilon was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
Yes
The pioneer or innovator of Tridesilon. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Tridesilon is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Clay Park Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Tridesilon.
Tridesilon
|
